Renalytix AI Company

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.
RenalytixAI’s technology platform will draw from distinct sources of patient data, including large electronic health records, predictive blood-based biomarkers and other genomic information for analysis by learning computer algorithms. RenalytixAI intends to build a deep, unique pool of kidney disease-related data for different AI-enabled applications designed to improve predictive capability and clinical utility over time.
Technology: Diagnostics
Industry: Personalized Medicine
Headquarters: Penarth, Vale of Glamorgan, The, United Kingdom
Founded Date: Undisclosed
Employees Number: 11-50
Funding Status: IPO

Visit Website
renalytix@walbrookpr.com
Register and Claim Ownership